Results 41 to 50 of about 1,076 (134)

Biochemistry and Clinical Biochemistry Department, Faculty of Veterinary Medicine, Benha University [PDF]

Benha Veterinary Medical Journal, 2016
Aiming to raise the levels of immunity induced in dogs by the cell culture inactivated rabies vaccine, bee venom BV wassubjected to investigate its immune stimulant effect in vaccinated dogs.
Khodeir H., El-Nahas M., El-Bagoury F., Eiaka M.   +3 more
doaj   +1 more source

Physiological and behavioural effects of continuous remifentanil‐xylazine administration in donkeys

Equine Veterinary Journal, Volume 58, Issue 5, Page 1390-1395, September 2026.
Abstract Background Remifentanil and xylazine are used as continuous infusions to facilitate standing surgery in horses. Their use for this purpose has not been reported in donkeys. Objectives To evaluate the behavioural, sedative, and cardiorespiratory effects of continuous intravenous infusion of remifentanil and xylazine in donkeys. Study Design Non‐
Kássia Fernanda Araújo Damasceno, Andressa Nunes Mouta, Larissa de Sant' Ana Alves, Kathryn Nóbrega Arcoverde, Herbert Reis Aragão, Jerson Marques Cavalcante, Valéria Veras de Paula   +6 more
wiley   +1 more source

Developments in rabies vaccines

Clinical and Experimental Immunology, 2012
SummaryThe development of vaccines that prevent rabies has a long and distinguished history, with the earliest preceding modern understanding of viruses and the mechanisms of immune protection against disease. The correct application of inactivated tissue culture-derived vaccines is highly effective at preventing the development of rabies, and very few
D J, Hicks, A R, Fooks, N, Johnson
openaire   +3 more sources

Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review

Veterinary Research, 2017
RABORAL V-RG® is an oral rabies vaccine bait that contains an attenuated (“modified-live”) recombinant vaccinia virus vector vaccine expressing the rabies virus glycoprotein gene (V-RG).
Joanne Maki, Anne-Laure Guiot, Michel Aubert, Bernard Brochier, Florence Cliquet, Cathleen A. Hanlon, Roni King, Ernest H. Oertli, Charles E. Rupprecht, Caroline Schumacher, Dennis Slate, Boris Yakobson, Anne Wohlers, Emily W. Lankau   +13 more
doaj   +1 more source

Use of Restricted Nursing and a Bovine Appeasing Substance on the Welfare, Growth Performance, and Response to Vaccination of Beef Calves at Weaning

Animal Research and One Health, Volume 4, Issue 3, Page 314-321, August 2026.
The effects of restricted nursing (RN) and the administration of a bovine appeasing substance (BAS) on days −8 and 0 in relation to weaning were evaluated. Both strategies were effective in improving the growth performance of beef calves. Regarding welfare, BAS ‐especially on day 0‐ was more effective than RN.
Denise E. Mussalafo, Marcelo Vedovatto, Aylpy R. D. Santos, Dalton M. Oliveira, Fabiana A. M. Sterza, Mariana Santos, Helena B. C. R. Batista, Jaíne G. Garcia, Andréa R. D. L. Souza   +8 more
wiley   +1 more source

Dog owners' intention to control rabies and their willingness to pay for rabies vaccine in Northwestern Ethiopia.

PLOS Global Public Health
Rabies is a viral disease that affects both animals and humans. Effectiveness of a rabies control measures depends on collaboration of dog owners. This study was conducted in North West Ethiopia to understand the intention and willingness to pay (WTP) of
Fentahun Mengie, Wudu Temesgen Jemberu, Yimer Mulugeta, Wassie Molla, Sefinew Alemu Mekonnen   +4 more
doaj   +1 more source

Drivers of bat researchers’ intent to adopt field hygiene practices

Conservation Biology, Volume 40, Issue 4, August 2026.
Abstract Infectious disease is a growing threat to wildlife, with zoonotic transmission most likely at the human–wildlife interface. One underappreciated activity at this interface is fieldwork with wild animals, but associated risks can be mitigated through field hygiene (FH) practices, such as using personal protective equipment and other appropriate
Joanna L. Coleman, Ewan A. Macdonald, Abigail L. Rutrough, Tanja M. Straka, Todd D. Little, Zachary Stickley, Tigga Kingston   +6 more
wiley   +1 more source

Persistence and booster response of rabies antibodies among health care workers with multiple vaccinations

Tropical Medicine and Health
Rabies is a fatal but vaccine-preventable disease. Health care workers (HCWs) in endemic areas may receive repeated rabies vaccination because of occupational exposure, yet data on long-term antibody persistence and booster response after multiple prior ...
Mark Joseph Castellano, Johanna Beulah Sornillo, Nobuo Saito, Akira Nishizono, Catalino Demetria, Leilanie Nacion, Beatriz Quiambao   +6 more
doaj   +1 more source

Inventory management practices: implications on the pharmaceuticals expenditure of rabies vaccine in public health facilities, Namibia

BMC Health Services Research, 2023
Background To achieve well-regulated distribution, storage, and utilization of the rabies vaccine, health facilities should adhere to standard operating procedures.
Alemnew Dessie Shibabaw, Hilma N. Nakambale, Varsha Bangalee   +2 more
doaj   +1 more source

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6584-6594, August 2026.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source